{"id":6498,"date":"2020-01-30T08:53:20","date_gmt":"2020-01-30T08:53:20","guid":{"rendered":"https:\/\/fibrosisquistica.org\/?p=6498"},"modified":"2021-04-21T08:05:29","modified_gmt":"2021-04-21T08:05:29","slug":"un-nuevo-compuesto-podria-ser-efectivo-para-abrir-el-canal-del-cloruro-en-todos-los-pacientes-con-fq","status":"publish","type":"post","link":"https:\/\/fibrosisquistica.org\/en\/un-nuevo-compuesto-podria-ser-efectivo-para-abrir-el-canal-del-cloruro-en-todos-los-pacientes-con-fq\/","title":{"rendered":"Un nuevo compuesto podr\u00eda ser efectivo para abrir el canal del cloruro en todos los pacientes con FQ"},"content":{"rendered":"<p>En una actualizaci\u00f3n reciente, se ha informado que el nuevo compuesto ETX001 de Enterprise Therapeutics podr\u00eda ser una prometedora terapia para la Fibrosis Qu\u00edstica al abrir el canal de cloruro TMEM16A (una ruta alternativa para equilibrar los niveles de sal \/ agua en la superficie de las c\u00e9lulas). Por lo tanto, ser\u00eda adecuado para todos los pacientes independientemente de su mutaci\u00f3n CFTR.<\/p>\n<p>Enterprise Therapeutics es una compa\u00f1\u00eda con sede en el Reino Unido que present\u00f3 su trabajo en el Congreso de FQ de\u00a0<a class=\"profileLink\" href=\"https:\/\/www.facebook.com\/cftrust\/?__tn__=K-R&amp;eid=ARCz7wzP_CA6PFTn0h39C2F_1sukp39P5qHcLvK0ffDdJ8osQtu41V2z4sQ9dzK6-W-Z0Noz_FZCNLF5&amp;fref=mentions&amp;__xts__%5B0%5D=68.ARCcd-90omIzGVaqUr-s-VykPUNpgXL0xgNGKiBUUuvUN13dBTmyjKCU8H2wZZk_K219_CW65jFPtI6OvSMbF2DPXfX8pN1qH7hR-7CAAiyJCAgq5tEB0YSgzER1QijllJ9K4LeI-AXNT4UqINxpcNhw33iImHfZdIP35wc-Y32PpyBYYi79Cc2PG4oEh4hZZk-BAxIWzj5Jdc1j-PxZa_ZSz72Sguh3khkQpncpBZCj06jvzhDqMK8lv8uHcHbj-TSUy1L9-ZbfRww7DAZ6vhKCpikHIrH-LWqoR_IK1moWYFOLv0tXzmWfpcrus4zi_sxFeQ9JKWQntm5UjPeloHeq5Ic86CqFauNk-Lhl2PKgTEbFPqpWsekgv8y647Ev1hcvzd8sPB84HI9xEpkNkUHQq4laY2b1owVAVF67NIaTT20rez6lq31k0qcUhH63BuTb9k3UmAkE-H0wgtkD9bgx3HjW91i4x6Bu60egxVPoa1Yws-PnwQ\" data-hovercard=\"\/ajax\/hovercard\/page.php?id=13061487491&amp;extragetparams=%7B%22__tn__%22%3A%22%2CdK-R-R%22%2C%22eid%22%3A%22ARCz7wzP_CA6PFTn0h39C2F_1sukp39P5qHcLvK0ffDdJ8osQtu41V2z4sQ9dzK6-W-Z0Noz_FZCNLF5%22%2C%22fref%22%3A%22mentions%22%7D\" data-hovercard-prefer-more-content-show=\"1\" rel=\"nofollow noopener\" target=\"_blank\">Cystic Fibrosis Trust<\/a>\u00a0en septiembre de 2019. Sus ensayos de fase inicial se realizar\u00e1n en el Reino Unido en 2021.<\/p>\n<p><strong>M\u00e1s informaci\u00f3n:\u00a0<\/strong><a href=\"http:\/\/ow.ly\/UNfs50y7ZdO?fbclid=IwAR32dD28CzcY_KqCfr9-GrN09L62bLgt5tK4Pm9TWynea2rWC8KFtJ6-sBQ\" target=\"_blank\" rel=\"noopener nofollow noreferrer\" data-ft=\"{&quot;tn&quot;:&quot;-U&quot;}\" data-lynx-mode=\"async\" data-lynx-uri=\"https:\/\/l.facebook.com\/l.php?u=http%3A%2F%2Fow.ly%2FUNfs50y7ZdO%3Ffbclid%3DIwAR32dD28CzcY_KqCfr9-GrN09L62bLgt5tK4Pm9TWynea2rWC8KFtJ6-sBQ&amp;h=AT1O6GweOvgEB8TZdEhi6RrFbdAWwlFZyzC9NYXutRneq6Qvl5cBj8kPTFEI_i9rPH2sGQlGoRevBUIM2w8volBri2Qs6kREUOMbjp5JIeBLF41m_G_JaLFmjxZgCUH5S0S0tyWW62xeCajbFeQE6u3Bzxb4YimKRmFA4DnUq9PM8XCh0PUrjj4XpoM68CWQukqLEatGz_hipEKDMWq4-WEkZTSvGPc7JgK-hSORKJN1wdjXn_nYj5LtxjRXAFaHrNHaAGm87U9jNdLf_IcNUGwjqXHVn9ie7H2dpGbfjfCq60ZXm09vIGTimc9SGzk2VgyEhkeLrEov4yu8clFDgc01Oe6oTjucnqZho24pDlwx5R_cgnLUsdJNxCGq7zmDL9bO1drBfFe5UQoY1pKCwTMr6yoUMh1PKv-Vl5uH_zG4wFXykCxdQuZGYmJlxOwJFFWMUSup7c4bswjQTSfjXiJMR2fJlZz-F68fv--Rm5XgmxREA4bcstEpP58Mtnepr3wxum1LX1tVglXWq9DBdfBdpNLw50HadjEHbFCGtHFdz-9dhhVPe0k-eiince5n5CvJHalZj5XXyGLyzD1nIc1ddaovfcDvZrWLWjP_mHAmj7E7VTseHf11dByKtwzeeAT66wC8nZBX7LXmuA2yhy13zzAec9hKdOCQoeCMefp3Om4Idi0xPifwpQBx4Si32MEmWzZV4gckkkmcTmx7Faf5v6Rf1iMNXUciPU-DywQ6abwWxK8QXjTPpQ7lBXQYR30xrQQNanGBUdlaX-ZS6nCxjEMxxFlWp7w4FRP4G2epzPl5WugT1LYgpEbKAL7tsJi3E_6PO3FAqrOPKzF2\">http:\/\/ow.ly\/UNfs50y7ZdO<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>En una actualizaci\u00f3n reciente, se&#8230;<\/p>","protected":false},"author":22,"featured_media":10033,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[64,29],"tags":[],"class_list":{"0":"post-6498","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-investigacion","8":"category-tratamiento"},"acf":[],"_links":{"self":[{"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/posts\/6498","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/users\/22"}],"replies":[{"embeddable":true,"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/comments?post=6498"}],"version-history":[{"count":1,"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/posts\/6498\/revisions"}],"predecessor-version":[{"id":11317,"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/posts\/6498\/revisions\/11317"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/media\/10033"}],"wp:attachment":[{"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/media?parent=6498"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/categories?post=6498"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fibrosisquistica.org\/en\/wp-json\/wp\/v2\/tags?post=6498"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}